Bessemer Group
HRMY icon

Bessemer Group’s Harmony Biosciences HRMY Stock Holding History

Bessemer Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Sell
530
-25
-5% -$789 ﹤0.01% 1999
2026
Q1 		$16K Buy
555
+318
+134% +$10.4K ﹤0.01% 1993
2025
Q4 		$9K Buy
237
+16
+7% +$526 ﹤0.01% 2132
2025
Q3 		$6K Buy
221
+50
+29% +$1.72K ﹤0.01% 2091
2025
Q2 		$6K Buy
171
+4
+2% +$129 ﹤0.01% 1970
2025
Q1 		$6K Buy
167
+46
+38% +$1.65K ﹤0.01% 1954
2024
Q4 		$4K Sell
121
-31
-20% -$1.06K ﹤0.01% 2068
2024
Q3 		$6K Buy
152
+66
+77% +$2.32K ﹤0.01% 1856
2024
Q2 		$3K Hold
86
– – ﹤0.01% 1848
2024
Q1 		$3K Sell
86
-125
-59% -$4.01K ﹤0.01% 1851
2023
Q4 		$7K Buy
211
+18
+9% +$502 ﹤0.01% 1670
2023
Q3 		$6K Buy
193
+158
+451% +$5.49K ﹤0.01% 1703
2023
Q2 		$1K Buy
+35
New +$1.21K ﹤0.01% 2163
2022
Q2 		– Sell
-93
Closed -$5K – 1936
2022
Q1 		$5K Hold
93
– – ﹤0.01% 1513
2021
Q4 		$4K Hold
93
– – ﹤0.01% 1642
2021
Q3 		$4K Hold
93
– – ﹤0.01% 1537
2021
Q2 		$3K Hold
93
– – ﹤0.01% 1476
2021
Q1 		$3K Buy
+93
New +$3.26K ﹤0.01% 1433

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's HRMY Position: Q2 2026 in Review

Bessemer Group reduced its Harmony Biosciences (HRMY) stake by 4.5% in Q2 2026, selling an estimated $789 and leaving 530 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

Bessemer Group first reported a position in HRMY in Q1 2021 and has held it in 18 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bessemer Group held 530 shares of Harmony Biosciences worth $20K as of Q2 2026.
  • Bessemer Group sold 25 Harmony Biosciences shares in Q2 2026, an estimated $789.
  • Harmony Biosciences made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1999 holding.
  • Bessemer Group first reported a position in Harmony Biosciences in Q1 2021 and has held it in 18 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.